Clinical trial
An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine
NCT02001233 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine
- Lead sponsor
- Sinovac Biotech Co., Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- October 31, 2014
- Enrollment
- 10,077 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.